Evidence map›Paper›PMID 38191887›Full record

ArticleNature communications2024

Genomic and panproteomic analysis of the development of infant immune responses to antigenically-diverse pneumococci.

Nicholas J Croucher, Joseph J Campo, Timothy Q Le, Jozelyn V Pablo, Christopher Hung, Andy A Teng, Claudia Turner, François Nosten, Stephen D Bentley, Xiaowu Liang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Analysis of risk factors for otitis media in hospitalized children aged ≤ 12 years with bacterial pneumonia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Nicholas J CroucherMRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, W12 0BZ, UK. n.croucher@imperial.ac.uk.ORCID 0000-0001-6303-8768
Joseph J CampoAntigen Discovery Inc, 1 Technology Drive, Irvine, CA, 92618, USA.ORCID 0000-0002-8652-0917
Timothy Q LeAntigen Discovery Inc, 1 Technology Drive, Irvine, CA, 92618, USA.
Jozelyn V PabloAntigen Discovery Inc, 1 Technology Drive, Irvine, CA, 92618, USA.
Christopher HungAntigen Discovery Inc, 1 Technology Drive, Irvine, CA, 92618, USA.
Andy A TengAntigen Discovery Inc, 1 Technology Drive, Irvine, CA, 92618, USA.
Claudia TurnerCambodia Oxford Medical Research Unit, Angkor Hospital for Children, Siem Reap, 9V54+8FQ, Cambodia.
François NostenCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7BN, UK.ORCID 0000-0002-7951-0745
Stephen D BentleyParasites & Microbes, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.ORCID 0000-0001-8094-3751
Xiaowu LiangAntigen Discovery Inc, 1 Technology Drive, Irvine, CA, 92618, USA.
Paul TurnerCambodia Oxford Medical Research Unit, Angkor Hospital for Children, Siem Reap, 9V54+8FQ, Cambodia.ORCID 0000-0002-1013-7815
David GoldblattGreat Ormond Street Institute of Child Health, University College London, London, WC1N 1EH, UK.ORCID 0000-0002-0769-5242
Antigen Discovery (United States) · USAngkor Hospital for Children · KHImperial College London · GBMahidol University · THUniversity College London · GBWellcome Sanger Institute · GB

Funding

Medical Research Council MR/R015600/1Wellcome TrustWellcome Trust 206194
6 · The paper itself

Abstract

Streptococcus pneumoniae (pneumococcus) is a nasopharyngeal commensal and respiratory pathogen. This study characterises the immunoglobulin G (IgG) repertoire recognising pneumococci from birth to 24 months old (mo) in a prospectively-sampled cohort of 63 children using a panproteome array. IgG levels are highest at birth, due to transplacental transmission of maternal antibodies. The subsequent emergence of responses to individual antigens exhibit distinct kinetics across the cohort. Stable differences in the strength of individuals' responses, correlating with maternal IgG concentrations, are established by 6 mo. By 12 mo, children develop unique antibody profiles that are boosted by re-exposure. However, some proteins only stimulate substantial responses in adults. Integrating genomic data on nasopharyngeal colonisation demonstrates rare pneumococcal antigens can elicit strong IgG levels post-exposure. Quantifying such responses to the diverse core loci (DCL) proteins is complicated by cross-immunity between variants. In particular, the conserved N terminus of DCL protein zinc metalloprotease B provokes the strongest early IgG responses. DCL proteins' ability to inhibit mucosal immunity likely explains continued pneumococcal carriage despite hosts' polyvalent antibody repertoire. Yet higher IgG levels are associated with reduced incidence, and severity, of pneumonia, demonstrating the importance of the heterogeneity in response strength and kinetics across antigens and individuals.

Indexed as

GenomicsStreptococcus pneumoniaeAdultAntigens, BacterialChildChild, PreschoolHumansImmunity, MucosalImmunoglobulin GInfantInfant, NewbornAntigens, BacterialImmunoglobulin G

Identifiers

PMID38191887
PMCPMC10774285
OpenAlexW4390669293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.